Jan van Lunzen

11.8k citations
145 papers · 6.2k · 1 hit paper · h-index 42

Impact in

  • Virology top 0.1%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV Research and Treatment 104
    • HIV/AIDS Research and Interventions 52
    • HIV/AIDS drug development and treatment 48

Jan van Lunzen

143 papers receiving 6.0k citations

Jan van Lunzen's Hit Papers

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study 2014 · 350 citations
3500+4+8Years since publication100200300

Peers

Jan van Lunzen
Comparison fields: 5 of 115
  • Virology 3.7k
  • Infectious Diseases 3.1k
  • Immunology 2.0k
  • Emergency Medicine 759
  • Epidemiology 1.3k
Replace Laurence Weiss with:
Laurence Weiss France
Cécile Goujard France
Colin Kovacs Canada
Luis J. Montaner United States
Giuseppe Tambussi Italy
Jeffrey Laurence United States
Georg M. N. Behrens Germany
Marijke Roos Netherlands
James O. Kahn United States
Michael A. Polis United States
Jan van Lunzen relative to Laurence Weiss France Laurence Weiss's profile →
Citations per field
00.5×1.5×2.0×
Laurence Weiss · 1×
Citations per year

Countries citing papers authored by Jan van Lunzen

Since Specialization
Citations

This map shows the geographic impact of Jan van Lunzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan van Lunzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan van Lunzen more than expected).

Fields of papers citing papers by Jan van Lunzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan van Lunzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan van Lunzen. The network helps show where Jan van Lunzen may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan van Lunzen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan van Lunzen Line = papers co-authored together Jan van Lunzen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Hit paper breakdown →
2014350
2 2012321
3 1999303
4 2008278
5 2011226
6 2013215
7 2007197
8 1998169
9 2015152
10 2010148
11 2008147
12 2005132
13 2014121
14 2007115
15 2008114
16 1997101
17 200995
18 201695
19 201392
20 201486

About Jan van Lunzen

Jan van Lunzen is a scholar working on Virology, Infectious Diseases, Immunology, Epidemiology and Emergency Medicine, having authored 145 papers that have together received 6.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (104 papers), HIV/AIDS Research and Interventions (52 papers), HIV/AIDS drug development and treatment (48 papers), Immune Cell Function and Interaction (30 papers), HIV-related health complications and treatments (17 papers), Cytomegalovirus and herpesvirus research (14 papers), Viral-associated cancers and disorders (11 papers) and T-cell and B-cell Immunology (9 papers). The work is most often cited by research in Virology (3.7k citations), Infectious Diseases (3.1k citations), Immunology (2.0k citations), Emergency Medicine (759 citations) and Epidemiology (1.3k citations). Jan van Lunzen has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Marcus Altfeld, Hans‐Jürgen Stellbrink, Paul Rácz, Julian Schulze zur Wiesch, Klara Tenner‐Racz, Hans‐Juergen Stellbrink, Bonaventura Clotet, Roberto Ortiz, Jörn E. Schmitz and Gerd Fätkenheuer. Their work appears in journals such as AIDS, Journal of the International AIDS Society, JAIDS Journal of Acquired Immune Deficiency Syndromes, HIV Medicine and Antiviral Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact